[Treatment for the elderly hypertensive patient with renal insufficiency]

Kazuhiro Kobayashi1, Yoshihiko Kanno, Hiromichi Suzuki

  • 1Department of Nephrology, Saitama Medical School.

Insights

Japanese hypertension guidelines recommend lower blood pressure for elderly patients. This study explores combination therapy for hypertensive elderly patients with renal insufficiency to minimize adverse effects.

Area of Science:

  • Nephrology
  • Cardiology
  • Geriatrics

Context:

  • The 2004 Japanese Society of Hypertension guideline (published 2005) advocated for lowering blood pressure in elderly hypertensive individuals.
  • Current guidelines lack specific targets for elderly hypertensive patients with renal insufficiency.
  • Adverse effects of antihypertensive agents are a concern in this population.

Purpose:

  • To propose a combination therapy approach for elderly hypertensive patients with renal insufficiency.
  • To reduce blood pressure effectively while minimizing adverse effects.
  • To address the gap in specific treatment recommendations for this patient group.

Summary:

  • A combination therapy using low-dose antihypertensive agents is proposed for elderly patients with hypertension and renal insufficiency.
  • Suggested combinations include renin-angiotensin system inhibitors (ACE inhibitors or ARBs) with calcium antagonists or diuretics.
  • This approach aims to achieve blood pressure reduction and mitigate potential side effects.

Impact:

  • Provides a therapeutic strategy for a vulnerable patient population.
  • Highlights the importance of tailored treatment for elderly hypertensive patients with comorbidities.
  • Contributes to optimizing blood pressure management in geriatric nephrology and cardiology.

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.